Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAA first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 7.74 | 23-10-2026 |
| 2 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 7.74 | 23-10-2026 |
| 3 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 7.74 | 23-10-2026 |
| 4 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 9.7 | 22-10-2026 |
| 5 | Moderna's cancer vaccine cuts melanoma recurrence risk in early trial: What we know | 0 | 7.73 | 26-08-2026 |
| 6 | Una vacuna personalizada contra el melanoma reduce un 42% el riesgo de recaída o muerte en un ensayo clínico | 0 | 5.9 | 23-10-2026 |
| 7 | After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward | 0 | 6.09 | 15-10-2026 |
| 8 | mRNA vaccine reduced melanoma recurrence risk 42% after surgery | 0 | 12.14 | 23-10-2026 |
| 9 | Melanoma vaccine reduces death or cancer recurrence by 42% | 0 | 12.93 | 23-10-2026 |